Pennsylvania Nurse Practitioner Prescriptive authority

As a condition for obtaining Certified Registered Nurse Practitioner certification applicants must hold either a current, unrestricted Pennsylvania single state or multistate registered nurse license or a multistate registered nurse license issued by another Compact state

Certified Registered Nurse Practitioners; Qualifications.--(a) The board may certify a licensed registered nurse as a certified registered nurse practitioner in a particular clinical specialty area if the nurse satisfies the requirements established by this act and regulations promulgated by the board.

*National certification*—Certification by a Board-recognized National certification organization which required passing a nurse practitioner National certifying examination in a specialty.

Authority and qualifications for prescribing, dispensing and ordering drugs. (b) To obtain prescriptive authority approval, a CRNP shall: (1) Successfully complete at least 45 hours of course work specific to advanced pharmacology in accordance with the following:

(ii) The course work shall be at an advanced level above a pharmacology course required by a professional nursing (RN) education program. (iii) The course work shall have been completed within 5 years immediately preceding the date the applicant applies for initial prescriptive authority approval.

*Prescriptive authority collaborative agreement*—The written and signed agreement between a CRNP with prescriptive authority and a collaborating physician in which they agree to the details of their collaboration

CRNP Practice. (a) A CRNP may collaborate only with physicians who hold a current license to practice in this Commonwealth. (b) When acting in collaboration with a physician as set forth in a collaborative agreement and within the CRNP’s specialty, a CRNP may: (1) Perform comprehensive assessments of patients and establish medical diagnoses

CRNP Practice. (a) A CRNP may collaborate only with physicians who hold a current license to practice in this Commonwealth. (b) When acting in collaboration with a physician as set forth in a collaborative agreement and within the CRNP’s specialty, a CRNP may: (1) Perform comprehensive assessments of patients and establish medical diagnoses

Prescribing and dispensing parameters. (b) A CRNP with current prescriptive authority approval from the Board may prescribe, dispense and administer drugs and therapeutic or corrective measures consistent with the prescriptive authority collaborative agreement and relevant to the CRNP’s specialty from the following categories: (1) Antihistamines.

(2) A CRNP may prescribe a Schedule III or IV controlled substance for up to a 90 day supply as identified in the collaborative agreement. (e) A CRNP may not delegate prescriptive authority.

(2) A CRNP may prescribe a Schedule III or IV controlled substance for up to a 90 day supply as identified in the collaborative agreement. (e) A CRNP may not delegate prescriptive authority.

nurse practitioners, by or pursuant to law or regulation shall, after the effective date of this subsection, be exercised solely by the State Board of Nursing.

Since DEA's authority to register practitioners to dispense (including to prescribe) controlled substances is contingent, in part, upon the applicant's authorization in the state in which he or she practices, his or her controlled substance privileges and limits are determined by that specific state.

DEA relies on State licensing boards to determine whether a practitioner is qualified to dispense, prescribe, or administer controlled substances and to determine which schedules he/she may dispense, prescribe, or administer.

DEA regulations require a separate registration for each principal place of business or professional practice at one general physical location where controlled substances are manufactured, distributed, imported, exported, or dispensed by a person.

21 CFR 1301.12(a), "A separate registration is required for each principal place of business or professional practice at one general physical location where controlled substances are manufactured, distributed, imported, exported, or dispensed by a person."

A mid-level practitioner means an individual practitioner, other than a physician, dentist, veterinarian, or podiatrist, who is licensed, registered, or otherwise permitted by the United States or the jurisdiction in which he/she practices, to dispense a controlled substance in the course of professional practice.

Examples of mid-level practitioners include, but are not limited to, health care providers such as nurse practitioners, nurse midwives, nurse anesthetists, clinical nurse specialists and physician assistants who are authorized to dispense controlled substances by the State in which they practice.

As a condition of biennial renewal of prescriptive authority approval, a CRNP shall complete a minimum of 16 of the 30 hours of Board-approved continuing education in pharmacology in the 2 years prior to renewal

If licensee has prescriptive authority approval, a minimum of 16 of the 30 hours of continuing education must be completed in pharmacology every two years

### Education Required for Biennial Renewal: To renew certification every two years, a licensee must complete 30 hours of continuing education applicable to the licensee's CRNP specialty, which must include 2 hours of approved training in how to recognize and report child abuse

Answer: All DEA-registered practitioners, with the exception of practitioners that are solely veterinarians.

Answer: Beginning on June 27, 2023, practitioners will be required to check a box on their online DEA registration form—regardless of whether a registrant is completing their initial registration application or renewing their registration—affirming that they have completed the new training requirement.

Answer: The deadline for satisfying this new training requirement is the date of a practitioner's next scheduled DEA registration submission—regardless of whether it is an initial registration or a renewal registration—on or after June 27, 2023.

This one-time training requirement affirmation will not be a part of future registration renewals.

It should be noted that this is a one-time attestation and trainings can occur in classroom settings, seminars at professional society meetings, or virtual offerings.

Fees. (a) The following application fees are charged by the Board for services to licensees and applicants: CRNP Certification—Board-approved nursing education program graduates $100 CRNP Certification—graduates of out-of-State nursing education programs $140 Verification of certification $45 Verification of certification with history $50 Application for prescriptive authority $95

Fees. Each additional application for prescriptive authority $45 Restoration of CRNP certification after suspension or revocation $60 Restoration of CRNP prescriptive authority after suspension or revocation $60 (b) The following renewal fees are charged by the Board to support its operations: Biennial renewal of CRNP certification $81 Biennial renewal of prescriptive authority approval $41

Each additional application for prescriptive authority $45 Restoration of CRNP certification after suspension or revocation $60 Restoration of CRNP prescriptive authority after suspension or revocation $60 (b) The following renewal fees are charged by the Board to support its operations: Biennial renewal of CRNP certification $81 Biennial renewal of prescriptive authority approval $41

Application for certification. (a) Applicants for certification shall pay a fee set forth in § 21.253 (relating to fees), and submit an application form provided by the Board to the Board for its review and approval.

Authority and qualifications for prescribing, dispensing and ordering drugs. (b) To obtain prescriptive authority approval, a CRNP shall: (1) Successfully complete at least 45 hours of course work specific to advanced pharmacology in accordance with the following:

(2) Submit an application for prescriptive authority approval to the Board

The Board does not believe it is necessary to repeat these statutory provisions because CRNPs are required to submit their prescriptive authority collaborative agreements on a form provided by the Board and the form includes the three provisions found in section 8.3(a)(2)(i)—(iii) of the act, as well as additional information that must be submitted to the Board

nurse practitioners, by or pursuant to law or regulation shall, after the effective date of this subsection, be exercised solely by the State Board of Nursing.

Certified Registered Nurse Practitioners; Qualifications.--(a) The board may certify a licensed registered nurse as a certified registered nurse practitioner in a particular clinical specialty area if the nurse satisfies the requirements established by this act and regulations promulgated by the board.

Since DEA's authority to register practitioners to dispense (including to prescribe) controlled substances is contingent, in part, upon the applicant's authorization in the state in which he or she practices, his or her controlled substance privileges and limits are determined by that specific state.

Answer: As a condition of registration, the new training requirement in section 1263(a) of the CAA went into effect on June 27, 2023, and applies to all qualified practitioners when they apply for a new registration or a renewal of registration on or after that date.